Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



The S&P Should Beat These Stocks Today

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

LONDON -- Stock markets are mixed in Europe Tuesday, with peripheral countries seeing a more upbeat session than their counterparts in the core EU. Yesterday's Labor Day holiday leaves many investors waiting to see how the U.S. markets open today, with hopes that they will catch up with the rally in European stocks at the start of the week. Meanwhile, all eyes are on the manufacturing report coming from the U.S. in hopes of an economic recovery, given last week's poor numbers from Asia and the EU. So far futures trading is offering little insight into the U.S. markets, with the S&P 500 (INDEX: ^GSPC  ) currently flat.

Nevertheless, there are still a number of companies suffering sharp losses. Here are three American depositary receipts the S&P should beat today.

Vodafone Group (Nasdaq: VOD  )
In a move counter to its new joint-venture partner, Telefonica (NYSE: TEF  ) , Vodafone is down more than 2% on news that it is set to win EU approval with Telefonica and Everything Everywhere to create a new U.K. mobile-phone payment platform. The European Commission is set to approve a deal as soon as this week, which will see Vodafone, Telefonica's U.K. unit, and the Everything Everywhere partnership combine in a new joint venture to create a platform that should allow easy mobile shopping and payment via smartphones. The commission began investigating concerns earlier this year that the group would be able to block competitors from offering their own "mobile wallet" to U.K. customers.

Sanofi (NYSE: SNY  )
The pharmaceutical giant is down almost 2% today after it said it plans to buy back up to $152 million worth of contingent value rights, linked to its purchase of Genzyme in 2011. CVRs are a tradable security that gives payouts to Genzyme investors if certain revenue targets are met, and this latest news of a buyback indicates Sanofi's growing confidence in Genzyme's multiple sclerosis drug Lemtrada. The company said it would purchase the CVRs for between $1.50 and $1.75 each -- a premium of between 7% and 25% of their market value, though still far below the $2.40 price tag at issuance.

Deutsche Bank (NYSE: DB  )
Deutsche Bank is down around 1.5% today after co-CEO Juergen Fitschen said profit margins in Europe's banking industry will remain under pressure. The comments, which many see as specifically reflecting the prospects of DB itself, suggest that the sovereign-debt crisis is curbing client activity in the banking sector, while at the same time, competition is increasing. Fitschen, speaking at a banking conference in Frankfurt today, said low margins and higher capital requirements are "the new normal" and warned that the industry cannot rely on the assumption that dramatic growth opportunities will solve its problems in a swift and timely fashion.

As usual, this morning's European trading saw some stocks lose ground -- and perhaps provide some European buying opportunities. Indeed, legendary investor Warren Buffett has recently spent more than $1 billion buying a European large-cap stock that's currently trading well below its 2012 high. If you want to know what Buffett has bought within Europe, this special Motley Fool report -- "The One European Share Warren Buffett Loves" -- reveals everything, including the price he paid. You can download the report today for free, but hurry -- it's available for a limited time only.

The Motley Fool is helping Europe invest. Better. And with the eurozone economy so uncertain, we're urging everyone to read "10 Steps To Making A Million In The Market" -- this report may transform your wealth. Click here now to request your free, no-obligation copy.

Further Motley Fool investment opportunities:

Karl Loomes does not own any share mentioned in this article. Motley Fool newsletter services have recommended buying shares of Vodafone Group. The Motley Fool has a disclosure policy.We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2004869, ~/Articles/ArticleHandler.aspx, 10/27/2016 10:45:56 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,175.71 -23.62 -0.13%
S&P 500 2,135.42 -4.01 -0.19%
NASD 5,241.08 -9.19 -0.18%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/27/2016 10:35 AM
^GSPC $2135.42 Down -4.01 -0.19%
S&P 500 INDEX CAPS Rating: No stars
DB $14.61 Up +0.05 +0.34%
Deutsche Bank CAPS Rating: **
SNY $37.63 Up +0.57 +1.55%
Sanofi CAPS Rating: *****
VOD $27.95 Down -0.02 -0.05%
Vodafone CAPS Rating: ****
TEF $9.91 Down -0.05 -0.50%
Telefonica CAPS Rating: ****